Drug Shortage Report for AURALGAN

Last updated on 2020-01-16 History
Report ID 85734
Drug Identification Number 02332477
Brand name AURALGAN
Common or Proper name Auralgan (Antipyrine/Benzocaine)
Company Name PALADIN LABS INC.
Market Status CANCELLED POST MARKET
Active Ingredient(s) ANTIPYRINE BENZOCAINE
Strength(s) 54MG 14MG
Dosage form(s) SOLUTION
Route of administration OTIC
Packaging size 14mL
ATC code S02DA
ATC description OTHER OTOLOGICALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-08-19
Estimated end date 2020-01-31
Actual end date 2020-01-15
Shortage status Resolved
Updated date 2020-01-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 100 BLVD ALEXIS-NIHON, SUITE 600
SAINT-LAURENT, QUEBEC
CANADA H4M 2P2
Company contact information 1-866-340-1112 paladincs@endo.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2020-01-16 English Compare
v19 2020-01-15 French Compare
v18 2020-01-15 English Compare
v17 2020-01-03 French Compare
v16 2020-01-03 English Compare
v15 2019-12-16 French Compare
v14 2019-12-16 English Compare
v13 2019-12-02 French Compare
v12 2019-12-02 English Compare
v11 2019-11-13 French Compare
v10 2019-11-13 English Compare
v9 2019-10-25 French Compare
v8 2019-10-25 English Compare
v7 2019-08-26 French Compare
v6 2019-08-26 English Compare
v5 2019-08-22 French Compare
v4 2019-08-22 English Compare
v3 2019-06-07 English Compare
v2 2019-06-06 French Compare
v1 2019-06-06 English Compare

Showing 1 to 20 of 20